Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06767501 · ClinicalTrials.gov registry record · NA
Clinical Trial Evaluating an Amnion Membrane Allograft for Use in the Management of Non- Healing Diabetic Foot Ulcers Versus Standard Of Care
A NA study of Diabetic Foot Ulcers (DFUs), sponsored by Skye Biologics Holdings.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06767501 is a NA study of Diabetic Foot Ulcers (DFUs) that is actively recruiting participants, run by Skye Biologics Holdings. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06767501, a NA study of Diabetic Foot Ulcers (DFUs), is actively recruiting participants, sponsored by Skye Biologics Holdings.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this research study is to compare the proportion of wound closure in subjects that receive E-GRAFT™ with Standard of Care (SOC) versus FIBRACOL™ with SOC. Other research purposes include the following: * Rate of wound closure * Change in ulcer size over 12 weeks * Any adverse events or reactions (side effects) * Changes in neuropathy (nerve damage) * Change in pain levels * Occurrence of infection
Conditions Studied
Interventions
- OTHER E-GRAFT ™
- DEVICE FIBRACOL™
Study Locations (1)
Virginia
- Professional Education and Research Institute - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-12-28 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06767501
The ClinicalTrials.gov registry entry for NCT06767501 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Skye Biologics Holdings, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot Ulcers (DFUs) appearing as the primary indexed condition, and to 2 interventions - of which E-GRAFT ™ is the first listed.
NCT06767501 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06767501 about?
NCT06767501 is a clinical study titled "Clinical Trial Evaluating an Amnion Membrane Allograft for Use in the Management of Non- Healing Diabetic Foot Ulcers Versus Standard Of Care". The main purpose of this research study is to compare the proportion of wound closure in subjects that receive E-GRAFT™ with Standard of Care (SOC) versus FIBRACOL™ with SOC. Other research purposes include the following: * Rate of wound closure * Change in ulcer size over 12 weeks * Any adverse ev...
What is the current status of trial NCT06767501?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-12-28. Estimated completion is 2025-12.
What conditions does trial NCT06767501 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcers (DFUs).
What interventions are being tested in trial NCT06767501?
The interventions under investigation include: E-GRAFT ™ (OTHER), FIBRACOL™ (DEVICE).
Who is sponsoring clinical trial NCT06767501?
This trial is sponsored by Skye Biologics Holdings, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06767501 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcers (DFUs)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.